Terms: = Breast cancer AND GATA1, ERYF1, P15976, 2623, ENSG00000102145, NFE1, GF1 AND Prognosis
4 results:
1. HDAC5 Loss Enhances Phospholipid-Derived Arachidonic Acid Generation and Confers Sensitivity to cPLA2 Inhibition in Pancreatic cancer.
Pan P; Qin G; Wang B; Yu H; Chen J; Liu J; Bing K; Shen J; Ren D; Zhao Y; Xia W; Li H; Wu H; Zhou Y
Cancer Res; 2022 Dec; 82(24):4542-4554. PubMed ID: 36102738
[TBL] [Abstract] [Full Text] [Related]
2. SENP1 promotes triple-negative breast cancer invasion and metastasis via enhancing CSN5 transcription mediated by gata1 deSUMOylation.
Gao Y; Wang R; Liu J; Zhao K; Qian X; He X; Liu H
Int J Biol Sci; 2022; 18(5):2186-2201. PubMed ID: 35342335
[TBL] [Abstract] [Full Text] [Related]
3. Perioperative inhibition of β-adrenergic and COX2 signaling in a clinical trial in breast cancer patients improves tumor Ki-67 expression, serum cytokine levels, and PBMCs transcriptome.
Haldar R; Shaashua L; Lavon H; Lyons YA; Zmora O; Sharon E; Birnbaum Y; Allweis T; Sood AK; Barshack I; Cole S; Ben-Eliyahu S
Brain Behav Immun; 2018 Oct; 73():294-309. PubMed ID: 29800703
[TBL] [Abstract] [Full Text] [Related]
4. GATA-binding protein 1 is a novel transcription regulator of peroxiredoxin 5 in human breast cancer cells.
Seo MJ; Liu X; Chang M; Park JH
Int J Oncol; 2012 Mar; 40(3):655-64. PubMed ID: 22020876
[TBL] [Abstract] [Full Text] [Related]
